169P Overall survival with first-line palbociclib plus an aromatase inhibitor (AI) vs AI in metastatic breast cancer: A large real-world database analysis
- Resource Type
- Abstract
- Source
- In
Annals of Oncology May 2022 33 Supplement 3:S202-S202 - Subject
- Language
- ISSN
- 0923-7534